Integrin β6 may functions through the protein kinase C (PKC) pathway in colon cancer, while β6 may also bind ERK and subsequently activate the ERK-Ets1 pathway in colon cancer and pancreatic cancer35. Here, PRRT2 is linked to malignant colon neoplasm.